TP53 and cervical cancer: Subsequently, we investigated whether the inhibitory effects on the proliferation rate (Fig 4A) and the changes in cell cycle distribution (Fig 4B) of cervical cancer cells in response to E6AP repression are also p53- and p21-dependent.